OptiNose Inc (OPTN)
1.01
+0.13
(+15.09%)
USD |
NASDAQ |
May 03, 16:00
1.003
-0.01
(-0.72%)
After-Hours: 20:00
OptiNose Max Drawdown (5Y): 94.79% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 94.79% |
| March 31, 2024 | 94.79% |
| February 29, 2024 | 94.79% |
| January 31, 2024 | 94.79% |
| December 31, 2023 | 94.79% |
| November 30, 2023 | 94.79% |
| October 31, 2023 | 94.79% |
| September 30, 2023 | 94.79% |
| August 31, 2023 | 94.79% |
| July 31, 2023 | 94.79% |
| June 30, 2023 | 94.79% |
| May 31, 2023 | 94.79% |
| April 30, 2023 | 94.79% |
| March 31, 2023 | 94.79% |
| February 28, 2023 | 94.79% |
| January 31, 2023 | 94.79% |
| December 31, 2022 | 94.79% |
| November 30, 2022 | 94.79% |
| October 31, 2022 | 94.79% |
| September 30, 2022 | 94.79% |
| August 31, 2022 | 94.79% |
| July 31, 2022 | 94.79% |
| June 30, 2022 | 94.79% |
| May 31, 2022 | 94.79% |
| April 30, 2022 | 94.79% |
| Date | Value |
|---|---|
| March 31, 2022 | 94.79% |
| February 28, 2022 | 94.79% |
| January 31, 2022 | 94.79% |
| December 31, 2021 | 94.79% |
| November 30, 2021 | 94.79% |
| October 31, 2021 | 92.10% |
| September 30, 2021 | 92.10% |
| August 31, 2021 | 92.10% |
| July 31, 2021 | 91.26% |
| June 30, 2021 | 90.22% |
| May 31, 2021 | 90.22% |
| April 30, 2021 | 89.25% |
| March 31, 2021 | 89.25% |
| February 28, 2021 | 89.25% |
| January 31, 2021 | 89.25% |
| December 31, 2020 | 89.25% |
| November 30, 2020 | 89.25% |
| October 31, 2020 | 89.25% |
| September 30, 2020 | 88.27% |
| August 31, 2020 | 88.27% |
| July 31, 2020 | 88.27% |
| June 30, 2020 | 88.27% |
| May 31, 2020 | 88.27% |
| April 30, 2020 | 88.27% |
| March 31, 2020 | 88.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
80.38%
Minimum
May 2019
94.79%
Maximum
Nov 2021
91.09%
Average
93.45%
Median
Max Drawdown (5Y) Benchmarks
| Zevra Therapeutics Inc | 99.27% |
| Madrigal Pharmaceuticals Inc | 82.20% |
| Viking Therapeutics Inc | 89.26% |
| Spero Therapeutics Inc | 96.92% |
| Karuna Therapeutics Inc (DELISTED) | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -40.24 |
| Beta (5Y) | -0.0986 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.91% |
| Historical Sharpe Ratio (5Y) | -0.524 |
| Historical Sortino (5Y) | -0.951 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.57% |